MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference in London on October 5, 2010. Coleman N. Lannum, Vice President, Investor Relations, will discuss the Company in a presentation scheduled to begin at 7:30AM ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.3 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.